Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Total 13F shares
-
5,556,294
-
Share change
-
+2,125,063
-
Total reported value
-
$88,004,478
-
Price per share
-
$15.84
-
Number of holders
-
43
-
Value change
-
+$33,701,269
-
Number of buys
-
22
-
Number of sells
-
18
Institutional Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q2 2014
As of 30 Jun 2014,
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,556,294 shares.
The largest 10 holders included
Aisling Capital LLC, Pentwater Capital Management LP, WASATCH ADVISORS INC, Polar Capital LLP, BlackRock Fund Advisors, VANGUARD GROUP INC, MORGAN STANLEY, Iguana Healthcare Management, LLC, DEUTSCHE BANK AG\, and FMR LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.